Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults

European Journal of Endocrinology

Volumn 135, Issue 6, 1996, Pages 672-677

  Skjærbæk, Christian ^a   Frystyk, Jan ^a   Møller, Jens ^a   Christiansen, Jens Sandahl ^a   Ørskov, Hans ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; PLACEBO; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030483609     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350672     Document Type: Article

References (25)

1. Frystyk J, Skjærbæk C, Dinesen B, Ørskov H. Free insulin-like growth factors (IGP-I and IGF-II) in human serum. FEBS Lett 1994;548:185-91
2. Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 1977;60:648-57
3. Zapf J, Walter H, Froesch ER. Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest 1981;68:1521-30
4. Deyssig R, Frisch H, Blum WF, Waldhör T. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol 1993;128:313-8
5. Crist DM, Peake GT, Egan PA, Waters DL. Body composition response to exogenous GH during training in highly conditioned adults. J Appl Physiol 1988;65:579-84
6. Crist DM, Peake GT, Loftfield RB, Kraner JC, Egan PA, Supplemental growth hromone alters body composition, muscle protein metabolism and serum lipids in fit adults: characterization of dose-dependent and response-recovery effects. Mech Ageing Dev 1991;58:191-205
7. Copeland KC, Underwood LE, Van Wyk JJ. Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. J Clin Endocrinol Metab 1980;50:690-7
8. Grant MB, Schmetz I, Russell B, Harwood HJJ, Silverstein J, Merimee TJ. Changes in insulin-like growth factors I and II and their binding protein after a single intramuscular injection of growth hormone. J Clin Endocrinol Metab 1986;63:981-4
9. Jorgensen JOL, Flyvbjerg A, Lauritzen T, Alberti KG, Ørskov H, Christiansen JS. Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients. J Clin Endocrinol Metab 1988;67:36-40
10. Møller J, Jorgensen JOL, Lauersen T, Frystyk J, Næraa RW, Ørskov H, et al. Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clin Endocrinol (Oxf) 1993;39:403-8
11. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebæk NE. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) 1994;41:85-93
12. Møller J, Jorgensen JOL, Frandsen E, Laursen T, Christiansen JS. Body fluids, circadian blood pressure and plasma renin during growth hormone administration: a placebo-controlled study with two growth hormone doses in healthy adults. Scand J Clin Lab Invest 1995;55:663-9
13. Frystyk J, Dinesen B, Ørskov H, Non-competitive time-resolved immunofluorometric assay for determination of human insulin-like growth factor I and II. Growth Regul 1995;5:169-76
14. Armitage P, Berry G. Comparison of several groups. In: Statistical methods in medical research. Oxford. Oxford: Blackwell Science, 1994:204-37
15. Takada M, Nakanome H, Kishida M, Hirose S, Hasegawa T, Hasegawa Y. Measurement of free insulin-like growth factor-I using immunoradiometric assay. J Immunoassay 1994;15: 263-76
16. Lieberman SA, Bukar J, Chen SA, Celniker AC, Compton PG, Cook J, et al. Effects of recombinant insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. J Clin Endocrinol Metab 1992;75:30-6
17. Zenobi PD, Graf S, Ursprung H, Froesch ER. Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion. J Clin Invest 1992;89:1908-13
18. Zapf J, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest 1986;77:1768-75
19. Hizuka N, Takano K, Asakawa K, Sukegawa I, Fukuda I, Demura H, et al. Measurement of free form of insulin-like growth factor I in human plasma. Growth Regul 1991;1:51-5
20. Cox GN, McDermott MJ, Merkel E, Stroh CA, Ko SC, Squires CH, et al. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology 1994; 135:1913-20
21. Lewitt MS, Denyer GS, Cooney GJ, Baxter RC, Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology 1991;129:2254-6
22. Taylor AM, Dunger DB, Preece MA, Holly JM, Smith CP, Wass JA, et al. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol (Oxf) 1990;52:229-39
23. Baxter RC. Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulatory IGF availability. Acta Paediatr Scand Suppl 1991;372:107-14
24. Frystyk J, Vestbo E, Skjærbæk C, Mogensen CE, Ørskov H. Free insulin-like growth factors in human obesity. Metabolism 1995;44 Suppl 4:37-44
25. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34